đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
A study to evaluate the safety, tolerability, and immunogenicity of a recom...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT00489099
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
The first purpose of this study is to test the body's protective reaction (...
Status
Completed
Location
University of Maryland, Baltimore, Center for Vaccine Development and Global Health
Start Date
2000-03-29
Trial ID
NCT04162223
Treatments Being Tested
The purpose of this trial is to determine if there is an improvement in the...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00440531
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0159)
Start Date
2019-06-19
Trial ID
NCT03893448
Treatments Being Tested
This is a study to evaluate immunogenicity, safety, and tolerability of 2XP...
Status
Completed
Location
Multiple Locations
Start Date
2011-11-29
Trial ID
NCT01463683
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and immun...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00551915
Treatments Being Tested
The goal of this study is to evaluate the safety, tolerability, and immunog...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0015)
Start Date
2018-10-18
Trial ID
NCT03620162
Treatments Being Tested
Hepatitis B Vaccine \[Recombinant\] is a well-established vaccine which has...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00322361
Treatments Being Tested
The purpose of this study was to evaluate the optimal vaccination schedule ...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-16
Trial ID
NCT01049035
Treatments Being Tested